Magna International (MGA) Investors: Susquehanna Maintains “Hold” Rating, Sees $57.0/Share; Shorts at DIASORIN S.R.L. SHARES ITALY (DSRLF) Lowered By 2.82%

March 15, 2018 - By Darrin Black

DIASORIN S.R.L. SHARES ITALY (OTCMKTS:DSRLF) had a decrease of 2.82% in short interest. DSRLF’s SI was 192,900 shares in March as released by FINRA. Its down 2.82% from 198,500 shares previously. With 300 avg volume, 643 days are for DIASORIN S.R.L. SHARES ITALY (OTCMKTS:DSRLF)’s short sellers to cover DSRLF’s short positions. The SI to DIASORIN S.R.L. SHARES ITALY’s float is 0.86%. It closed at $84.746353 lastly. It is down 0.00% since March 15, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 14 analysts covering Magna International (NYSE:MGA), 9 have Buy rating, 1 Sell and 4 Hold. Therefore 64% are positive. Magna International has $75 highest and $41.0 lowest target. $61.20’s average target is 8.26% above currents $56.53 stock price. Magna International had 52 analyst reports since August 6, 2015 according to SRatingsIntel. RBC Capital Markets maintained the stock with “Buy” rating in Sunday, October 29 report. KeyBanc Capital Markets maintained the shares of MGA in report on Tuesday, January 16 with “Buy” rating. BMO Capital Markets maintained the stock with “Hold” rating in Tuesday, August 1 report. The rating was maintained by RBC Capital Markets with “Outperform” on Friday, January 6. As per Friday, August 14, the company rating was maintained by Deutsche Bank. KeyBanc Capital Markets maintained Magna International Inc. (NYSE:MGA) on Thursday, September 14 with “Buy” rating. The firm has “Outperform” rating given on Monday, February 27 by Macquarie Research. The rating was maintained by RBC Capital Markets with “Buy” on Wednesday, January 10. The firm earned “Buy” rating on Sunday, September 17 by RBC Capital Markets. RBC Capital Markets maintained Magna International Inc. (NYSE:MGA) rating on Thursday, February 22. RBC Capital Markets has “Buy” rating and $71.0 target.

DiaSorin S.p.A. engages in the development, production, and commercialization of diagnostic tests that are designed for hospital and private testing laboratories for use in various clinical areas in the market of immunodiagnostics and molecular diagnostics. The company has market cap of $5.04 billion. The firm offers immunodiagnostics products in the areas of infectious diseases; bone and mineral metabolism; endocrinology, including diabetes, thyroid function, fertility, growth, adrenal function, and gastroenterology; hypertension; oncology; gastrointestinal infections; autoimmunity; and cardiac and brain damages. It has a 30 P/E ratio. The Company’s immunodiagnostics systems include LIAISON XL, an automated chemiluminescence analyzer; LIAISON analyzer; ETI Max 3000, an automated microtiter plate analyzer; EVOlyzer 2-150/8 with disposable tips; and ELISA washers and readers.

Analysts await Magna International Inc. (NYSE:MGA) to report earnings on May, 10. They expect $1.67 EPS, up 9.15% or $0.14 from last year’s $1.53 per share. MGA’s profit will be $607.08 million for 8.46 P/E if the $1.67 EPS becomes a reality. After $1.57 actual EPS reported by Magna International Inc. for the previous quarter, Wall Street now forecasts 6.37% EPS growth.

Magna International Inc. designs, develops, and makes automotive systems, assemblies, modules, and components in North America, Europe, Asia, and South America. The company has market cap of $20.55 billion. The firm offers engineering and contract manufacturing services, and fuel systems; electric/electronic components and systems; roof systems comprising softtops, retractable hardtops, modular tops, and hardtops; and closures, including latching systems, hinges and wire forming, power closures, electronics, door modules, window systems engineered glass, sealing, trim and roof racks, roof systems, testing centers, and running boards. It has a 9.58 P/E ratio. It also provides interior and exterior mirrors, actuators, electronic vision systems, door handle and overhead console technologies, and front and signal lightings; complete seating systems, mechanism solutions, seat structure solutions, foam and trim products, and design and development solutions; and fascia and exterior trims, liftgate and exterior modules, front end modules, ACTERO active aerodynamics, and lightweight composites.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: